AG00IB5C

63074-08-8 | Piperazine,1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]-, monohydrochloride

Chemical structure of Piperazine,1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]-, monohydrochloride, CAS 63074-08-8
AG00IB5C
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 63074-08-8
Catalog Number AG00IB5C(AGN-PC-0T7525)
Chemical Name Piperazine,1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]-, monohydrochloride
IUPAC Name [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(oxolan-2-yl)methanone;hydrochloride
InChI InChI=1S/C19H25N5O4.ClH/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14;/h10-11,14H,3-9H2,1-2H3,(H2,20,21,22);1H
InChI Key IWSWDOUXSCRCKW-UHFFFAOYSA-N
MDL Number MFCD00941408
Molecular Formula C19H26ClN5O4
Molecular Weight 423.8938
NSC Number 759168
SMILES O=C(N1CCN(C2=NC(N)=C3C=C(OC)C(OC)=CC3=N2)CC1)C4OCCC4.[H]Cl
Synonyms
A 45975, Adecur, Apo-Terazosin, Deflox, Dysalfa, Flotrin, Heitrin, Hytrin, Hytrin BPH, Hytrine, Magnurol, Novo-Terazosin, Nu-Terazosin, PMS-Terazosin, ratio-Terazosin, Sutif, Tazusin, Terazoflo, terazosin, Terazosin AZU, Terazosin Hexal, Terazosin hydrochloride, terazosin hydrochloride anhydrous, terazosin, monohydrochloride, dihydrate, Terazosina Alter, Terazosina Kern, Terazosina Qualix, Zayasel, Terazosin hydrochloride, 63074-08-8, Hytrin, Terazosin HCl, Vasocard, Flumarc, Fosfomic, Blavin, Abbott-45975, Zayasel, Terazosin hydrochloride anhydrous, (4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)(tetrahydrofuran-2-yl)methanone hydrochloride, MLS000040261, SMR000044015, DSSTox_CID_25493, DSSTox_RID_80913, DSSTox_GSID_45493, 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]piperazine hydrochloride, 6,7-dimethoxy-2-[4-(oxolane-2-carbonyl)piperazin-1-yl]quinazolin-4-amine hydrochloride, 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)4-[(tetrahydro-2-furanyl)carbonyl]piperazine hydrochloride, Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)-, monohydrochloride, CAS-63074-08-8, MFCD00467965, SR-01000000197, A-45975, Prestwick_146, terazosine hydrochloride, Tetrazosin hydrochloride, Opera_ID_398, AC1L2BPY, NCGC00016903-01, SCHEMBL41545, Terazosin hydrochloride,pharma, MLS001077301, MLS001305722, C19H25N5O4.HCl, CHEMBL1256665, DTXSID7045493, KS-00000JKM, IWSWDOUXSCRCKW-UHFFFAOYSA-N, HMS1570G04, Pharmakon1600-01505576, BCP12795, Tox21_110674, NSC759168, s4679, AKOS007930686, Tox21_110674_1, AC-2074, CCG-220751, LP01138, NE45355, NSC-759168, TRA0127916, VA11840, TERAZOSIN HYDROCHLORIDE (anhydrous), NCGC00016026-10, NCGC00094404-01, NCGC00094404-02, AK307521, AN-14324, DS-11401, AB1009460, AB2000463, DB-018541, LS-110235, TL8004930, TR-037527, EU-0101138, FT-0605647, V1531, T 4680, Terazosin hydrochloride, >=98% (TLC), powder, 074T088, I06-0651, SR-01000000197-2, SR-01000000197-4, SR-01000000197-12, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)-piperazine hydrochloride, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride, 2[4-(Tetrahydro-2-furoy1)piperazinyl]-4-amino-6,7-dimethoxyquinazoline hydrochloride, 4-Amino-6,7-dimethoxy-2-[4-(tetrahydro-2-furoyl)-1-piperazinyl]quinazoline Hydrochloride, [4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-tetrahydrofuran-2-yl-methanone hydrochloride, [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(oxolan-2-yl)methanone hydrochloride, 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonxyl]piperazine Hydrochloride, 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]-piperazine hydrochloride, Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)-,monohydrochloride, Piperazine,1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]-, monohydrochloride, Terasin, terazosin, Terazosine, terazosinhydrochloride, Prazosin hydrochloride, UNII-8QOP8Z9955, Terazosin hydrochloride dihydrate, 8QOP8Z9955, CID44383, C19-H25-N5-O4.Cl-H, Terazosin monohydrochloride anhydrous, ACN-040056, CS-O-02479, T2751, 70024-40-7, 63590-64-7, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)4-[(tetrahydro-2-furanyl)carbonyl]piperazine, 141269-45-6,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited